- Myogrel (Clopidogrel 75mg), is an Egyptian antiplatelet brand, indicated to reduce the risk of thrombotic events, in patients with acute coronary syndromes, recent stroke, transient ischemic attacks or established peripheral arterial disease.
- Myogrel has been launched in the Egyptian market, by Adwia pharmaceutical company, since November 2005.
- Myogrel is manufactured in Adwia company under the supervision of two ISO certificates (ISO 9001 & ISO 14001). To visit the full website of Adwia, click here.
- Myogrel reaches your patient in a high quality pack; double Aluminum strip, to protect the drug from light & moisture throughout shelf life.
- Myogrel had been recommended in 10 University hospitals, and has been prescribed in over 150,000 Rx by physicians all over Egypt.
- Myogrel was proved to be bioequivalent with the reference brand (bioequivalnce study, center of applied research & advanced studies, Cairo University, 2006).
- Myogrel is offered with an optimum price; 120 LE / 30 tablets, saving 45% from the monthly cost of the reference Clopidogrel.
Myogrel, A Brand You Can Trust.
